Pmv Pharmaceuticals Stock Alpha and Beta Analysis

PMVP Stock  USD 1.39  0.03  2.11%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Pmv Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Pmv Pharmaceuticals over a specified time horizon. Remember, high Pmv Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Pmv Pharmaceuticals' market risk premium analysis include:
Beta
0.79
Alpha
(0.32)
Risk
2.26
Sharpe Ratio
(0.07)
Expected Return
(0.16)
Please note that although Pmv Pharmaceuticals alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Pmv Pharmaceuticals did 0.32  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Pmv Pharmaceuticals stock's relative risk over its benchmark. Pmv Pharmaceuticals has a beta of 0.79  . As returns on the market increase, Pmv Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Pmv Pharmaceuticals is expected to be smaller as well. At this time, Pmv Pharmaceuticals' Price Book Value Ratio is relatively stable compared to the past year. As of 02/16/2025, Price Fair Value is likely to grow to 0.62, while Book Value Per Share is likely to drop 2.91.

Enterprise Value

330.32 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Pmv Pharmaceuticals Backtesting, Pmv Pharmaceuticals Valuation, Pmv Pharmaceuticals Correlation, Pmv Pharmaceuticals Hype Analysis, Pmv Pharmaceuticals Volatility, Pmv Pharmaceuticals History and analyze Pmv Pharmaceuticals Performance.
To learn how to invest in Pmv Stock, please use our How to Invest in Pmv Pharmaceuticals guide.

Pmv Pharmaceuticals Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Pmv Pharmaceuticals market risk premium is the additional return an investor will receive from holding Pmv Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pmv Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Pmv Pharmaceuticals' performance over market.
α-0.32   β0.79

Pmv Pharmaceuticals expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Pmv Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Pmv Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Pmv Pharmaceuticals Market Price Analysis

Market price analysis indicators help investors to evaluate how Pmv Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pmv Pharmaceuticals shares will generate the highest return on investment. By understating and applying Pmv Pharmaceuticals stock market price indicators, traders can identify Pmv Pharmaceuticals position entry and exit signals to maximize returns.

Pmv Pharmaceuticals Return and Market Media

The median price of Pmv Pharmaceuticals for the period between Mon, Nov 18, 2024 and Sun, Feb 16, 2025 is 1.51 with a coefficient of variation of 6.77. The daily time series for the period is distributed with a sample standard deviation of 0.1, arithmetic mean of 1.51, and mean deviation of 0.09. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Discover 3 US Penny Stocks With Market Caps Over 40M
12/03/2024
2
Disposition of 17709 shares by David Mack of Pmv Pharmaceuticals at 0.53 subject to Rule 16b-3
01/03/2025
3
PMV Pharmaceuticals stock hits 52-week low at 1.4 amid market challenges - Investing.com
01/13/2025
4
PMV Pharmaceuticals, Inc. Sees Significant Drop in Short Interest - MarketBeat
02/14/2025

About Pmv Pharmaceuticals Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Pmv or other stocks. Alpha measures the amount that position in Pmv Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Pmv Pharmaceuticals Upcoming Company Events

As portrayed in its financial statements, the presentation of Pmv Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pmv Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Pmv Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Pmv Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Pmv Pharmaceuticals' management manipulating its earnings.
6th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Pmv Pharmaceuticals

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Pmv Stock Analysis

When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.